Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
Active, not recruiting · NCT04028063 · Registry updated 2026-04-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Active, not recruiting | Phase 2 | 2026-04-20 | NCT04028063 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Agenus Inc. | 23 |
| University of Colorado, Denver | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Of Colorado Hospital | Aurora | United States | 106 |